CVRx Inc.
Last updated September 27, 2026
Organization details
- Legal name
- CVRx Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Minneapolis
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CVRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001235912
Board of directors
- Since 2023
-
Joseph P. Slattery · DirectorSince 2023
-
Kevin Hykes · Director · PRES & CEOSince 2023
-
Kevin J. Ballinger · DirectorSince 2024
-
Kirk G. Nielsen · DirectorSince 2023
-
Martha Shadan · DirectorSince 2023
-
Michael D. Dale · DirectorSince 2026
-
Mitch C. Hill · DirectorSince 2024
-
Mudit K. Jain · DirectorSince 2023
-
Nadim Yared · Director · CHIEF EXECUTIVE OFFICERSince 2023
Chief executives
Kevin Hykes
· PRES & CEO
Dates unknown
Nadim Yared
· CHIEF EXECUTIVE OFFICER
Dates unknown
Director election results
Annual meeting of June 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.9%
-
90.6%
-
99.8%
Board connections
5 of this board's directors also sit on 10 other boards.
- via Ali Behbahani and Kirk G. Nielsen
- via Michael D. Dale
- via Ali Behbahani
- via Ali Behbahani
- via Joseph P. Slattery
- via Ali Behbahani
- via Martha Shadan
- via Ali Behbahani
- via Ali Behbahani
- via Joseph P. Slattery
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $376,864
- 3 purchases by 2 insiders
- Sold, last 12 months
- $766,874
- 12 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent Officer (CHIEF OPERATING OFFICER) | Open-market purchase | +26,223 | $2.91 | $76,432 |
| Aug 12, 2026 | Binkowski Brent Officer (CHIEF OPERATING OFFICER) | Open-market sale | −1,309 | $2.55 | $3,338 |
| Jun 1, 2026 | Kirk G. Nielsen Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Mudit K. Jain Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Joseph P. Slattery Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Mitch C. Hill Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Kevin J. Ballinger Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Martha Shadan Director | Grant or award | +8,720 | — | — |
| Jun 1, 2026 | Michael D. Dale Director | Grant or award | +29,005 | — | — |
| Mar 2, 2026 | Morrison Gregory Officer (CHIEF HUMAN RESOURCES OFFICER) | Grant or award | +34,000 | — | — |
| Mar 2, 2026 | Adamson Philip B. Officer (Chief Medical Officer) | Open-market sale | −1,262 | $7.90 | $9,970 |
| Mar 2, 2026 | Kevin Hykes Director, Officer (PRES & CEO) | Open-market sale | −7,763 | $7.90 | $61,328 |
| Mar 2, 2026 | VERRASTRO PAUL Officer (CHIEF MKTG & STRAT OFFICER) | Open-market sale | −1,284 | $7.90 | $10,144 |
| Mar 2, 2026 | OASHEIM JARED Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | −1,744 | $7.90 | $13,778 |
| Mar 2, 2026 | John Robert Allen Officer (Chief Revenue Officer) | Open-market sale | −3,964 | $7.90 | $31,316 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.